Intimation of approval received for listing of 20,79,409 equity shares of ?5/- each allotted pursuant to conversion of warrants issued on preferential basis
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bajaj Healthcare has received listing approvals from both NSE and BSE for 20,79,409 equity shares of face value ₹5 each. These shares were issued at a premium of ₹333 per share (total issue price ₹338) to both Promoters and Non-Promoters through conversion of convertible warrants on preferential basis. The shares carry distinctive numbers from 31583253 to 33662661. Trading approval will be granted after confirmation from depositories (NSDL/CDSL) about crediting beneficiary accounts.
This is a dilutive event as approximately 20.79 lakh new equity shares will be listed, increasing the company's paid-up capital. Existing shareholders will see their percentage ownership reduced. The warrant holders (including promoters) have exercised their conversion option at ₹338 per share.